"The American Academy of Neurology (AAN), clinicians should prescribe as much as 100 mg of tetrabenazine per day, between 300 and 400 mg of amantadine per day, or 200 mg of riluzole per day to treat patients with Huntington's disease chorea, according to a new American Academy of Neurology (AAN) guideline published in the July 18 issue of Neurology. Based on the evidence, the guideline recommends that if HD chorea requires treatment, "clinicians may prescribe tetrabenazine (up to 100 mg/day), amantadine (300 to 400 mg/day), or riluzole (200 mg/day) (Level B) for varying degrees of expected benefit."

According to the report, Continuous Research and Development in Chorea Treatment is one of the primary growth factors for the market. Rising Prevalence of Genetic Conditions, such as Huntington’s Disease is also expected to contribute significantly to the Chorea Treatment market. Overall, Hospitals applications of Chorea Treatment, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The Treatment, such as Medication, is boosting the Chorea Treatment market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Diagnosis, such as Blood Tests, is boosting the Chorea Treatment market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The End User, such as Adults, is boosting the Chorea Treatment market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

New technologies and major shifts in the industry will be game-changing factors that all players have to react now in order to maintain strong positions in the future. As many industry experts agree that significant changes are ahead. AMA’s Analyst on the Global Chorea Treatment market identified that the demand is rising in many different parts of the world as "Awareness about Neurological Problems will Boost the Chorea Treatment Market ". Furthermore, some recent industry insights like "In 2019, Teva Pharmaceutical Industries Ltd. announced the Phase 2/3 ARTISTS 1 and Phase 3 ARTISTS 2 trials developed to evaluate deutetrabenazine compared to placebo for the treatment of tics for chorea treatment failed to meet the primary endpoint of reduction in motor and phonic tics. In the data received this week, the most commonly reported adverse event in the ARTISTS 1 and ARTISTS 2 studies were headache, somnolence, and fatigue. In this population, no new safety signals were identified that were inconsistent with the known safety profile of deutetrabenazine." which is constantly making the industry very dynamic.

The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Chorea Treatment market according to Type, Application, and regions
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key drivers & trends of the market

**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2022 currency rates.

Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Chorea Treatment market and other related sub-markets covered in the study.

o Key & emerging players in the market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation
The overall Chorea Treatment market size is calculated using market estimation process, the Chorea Treatment market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Chorea Treatment market size has been validated using both top-down and bottom-up approaches.